Proliferation rate of stem cells derived from human dental pulp and identification of differentially expressed genes

Abstract

Stem cells from human exfoliated deciduous teeth (SHED) and dental pulp stem cells (DPSCs) obtained from the dental pulp of human extracted tooth were cultured and characterized to confirm that these were mesenchymal stem cells. The proliferation rate was assessed using AlamarBlue® cell assay. The differentially expressed genes in SHED and DPSCs were identified using the GeneFishing™ technique. The proliferation rate of SHED (P < 0.05) was significantly higher than DPSCs while SHED had a lower multiplication rate and shorter population doubling time (0.01429, 60.57 h) than DPSCs (0.00286, 472.43 h). Two bands were highly expressed in SHED and three bands in DPSCs. Sequencing analysis showed these to be TIMP metallopeptidase inhibitor 1 (TIMP1), and ribosomal protein s8, (RPS8) in SHED and collagen, type I, alpha 1, (COL1A1), follistatin-like 1 (FSTL1), lectin, galactoside-binding, soluble, 1, (LGALS1) in DPSCs. TIMP1 is involved in degradation of the extracellular matrix, cell proliferation and anti-apoptotic function and RPS8 is involved as a rate-limiting factor in translational regulation; COL1A1 is involved in the resistance and elasticity of the tissues; FSTL1 is an autoantigen associated with rheumatoid arthritis; LGALS1 is involved in cell growth, differentiation, adhesion, RNA processing, apoptosis and malignant transformation. This, along with further protein expression analysis, holds promise in tissue engineering and regenerative medicine.

How has dental pulp stem cells isolation been conducted? A scoping review

“…This is probably due to the widespread use of FBS in published studies on DPSCs culture. 2,34 However, serum from animal source can present disadvantages such as risks of infections and immunological reactions. Indeed, mesenchymal stem cells have been reported to express N-glycolylneuraminic acid (Neu5Gc) xenoantigen that humans are unable to synthesize, indicating that cells uptake them from the culture media components.…”

Stem Cells of Dental Origin: Current Research Trends and Key Milestones towards Clinical Application

“…Among the important advantages of dental MSCs compared to other SC sources, such as bone marrow and adipose tissues, are their higher proliferative capacity, facilitating ex vivo expansion in sufficient cell numbers [26, 27]; easy isolation by noninvasive routine clinical procedures (e.g., extraction of impacted third molars or premolars for orthodontic reasons); and the absence, as reported so far, of major adverse reactions, concerning, for example, teratoma formation following in vivo application [28]. Previous studies have shown that DPSCs have the ability to produce single-cell derived Colony Forming Units (CFUs), survive for longer periods without undergoing senescence, and exhibit higher (80–100 times) proliferation rates than BMMSCs [1].…”

Dental pulp stem cells and the management of neurological diseases: An update

“…To date, there aren't any reports of cancer formation caused by transplantation of DPSCs, unlike cases of induced pluripotent stem cells or embryonic stem cells. Ethical considerations and immune‐compatibility problems usually faced with totipotent and pluripotent stem cells are absent with DPSCs since they are isolated from an easily accessible autologous source (Abdullah et al, ; Zhao, Wang, et al, ).…”